# SiNtx Technologies Inc. (SINT)

Source: https://www.quantisnow.com/company/SINT
Generated: 2026-11-09T08:19:44.397Z

- Ticker: SINT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2014
- SEC CIK: 0001269026
- Website: sintx.com

## About

Sintx Technologies, Inc., an advanced materials company, researches, develops, manufactures, and commercializes silicon nitride ceramics in the United States, Europe, and South America. It offers ceramic based solutions for various medical, industrial, and antipathogenic applications. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products. It has a collaboration agreement with Oxford Performance Materials, Inc. to develop a poly-ether-ketone-ketone silicon nitride composite based on OXPEKK SC solution casting technology. The company was formerly known as Amedica Corporation and changed its name to Sintx Technologies, Inc. in October 2018. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

## Latest SINT news and filings

- 2026-11-05 21:03 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-results-of-operations-6775990)
- 2026-11-05 21:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sintx-technologies-inc-6775953)
- 2026-11-05 21:02 UTC [Earnings] [SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization](https://www.quantisnow.com/insight/sintx-reports-record-third-quarter-2026-revenue-growth-and-advances-6775941)
- 2026-10-30 20:05 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-sintx-technologies-inc-6765188)
- 2026-10-22 13:00 UTC [Earnings Date] [SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast](https://www.quantisnow.com/insight/sintx-technologies-announces-third-quarter-2026-earnings-release-date-and-6754620)
- 2026-10-09 21:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-sintx-technologies-inc-6743150)
- 2026-10-01 13:05 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-results-of-operations-6731788)
- 2026-10-01 13:00 UTC [SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance](https://www.quantisnow.com/insight/sintx-announces-preliminary-22-million-in-q3-revenue-exceeding-high-end-6731712)
- 2026-09-14 13:00 UTC [SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts](https://www.quantisnow.com/insight/sintx-technologies-announces-silicon-nitride-masterclass-with-leading-orthopedics-experts-6713942)
- 2026-09-08 12:00 UTC [Conference Announcement] [SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference](https://www.quantisnow.com/insight/sintx-technologies-to-present-at-the-hc-wainwright-28th-annual-6707528)
- 2026-08-19 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-sintx-technologies-inc-6687642)
- 2026-08-13 13:05 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-regulation-fd-disclosure-6679635)
- 2026-08-13 13:00 UTC [SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement](https://www.quantisnow.com/insight/sintx-technologies-regains-compliance-with-nasdaq-stockholders-equity-requirement-6679591)
- 2026-08-11 20:10 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-results-of-operations-6675826)
- 2026-08-11 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sintx-technologies-inc-6675708)
- 2026-08-11 20:06 UTC [SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives](https://www.quantisnow.com/insight/sintx-technologies-provides-mid-year-2026-business-update-highlighting-commercial-execution-6675676)
- 2026-07-28 13:00 UTC [Earnings Date] [SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast](https://www.quantisnow.com/insight/sintx-technologies-announces-second-quarter-2026-earnings-release-date-and-6650889)
- 2026-07-23 13:05 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-regulation-fd-disclosure-6646563)
- 2026-07-23 13:00 UTC [SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program](https://www.quantisnow.com/insight/sintx-technologies-engages-veteran-medtech-executive-chris-lyons-and-southern-6646504)
- 2026-07-02 21:00 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-entry-into-a-6626263)
- 2026-07-01 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-sintx-technologies-inc-6621651)
- 2026-06-24 23:46 UTC [SEC Form S-3] [SEC Form S-3 filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-sintx-technologies-inc-6614927)
- 2026-06-22 13:00 UTC [SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders](https://www.quantisnow.com/insight/sintx-technologies-announces-receipt-of-more-than-32-million-in-6610199)
- 2026-06-09 21:12 UTC [SEC Form SCHEDULE 13G filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-sintx-technologies-inc-6595813)
- 2026-06-03 13:30 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-entry-into-a-6586182)
- 2026-06-03 13:00 UTC [SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules](https://www.quantisnow.com/insight/sintx-technologies-announces-raise-of-approximately-50-million-of-capital-6586101)
- 2026-05-27 19:00 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-notice-of-delisting-6574487)
- 2026-05-15 21:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sintx-technologies-inc-6558280)
- 2026-04-14 12:30 UTC [SEC Form 4] [SEC Form 4 filed by Elmore Robert Ryan](https://www.quantisnow.com/insight/sec-form-4-filed-by-elmore-robert-ryan-6498928)
- 2026-04-13 13:01 UTC [Analyst Coverage Initiated] [H.C. Wainwright initiated coverage on SINTX Technologies with a new price target](https://www.quantisnow.com/insight/hc-wainwright-initiated-coverage-on-sintx-technologies-with-a-new-6497464)
- 2026-03-23 13:15 UTC [Leadership Update] [SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution](https://www.quantisnow.com/insight/sintx-technologies-provides-corporate-business-update-highlighting-first-human-implant-6464576)
- 2026-03-20 21:00 UTC [SEC Form 10-K] [SEC Form 10-K filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-sintx-technologies-inc-6463629)
- 2026-03-19 11:30 UTC [SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant](https://www.quantisnow.com/insight/sintx-technologies-announces-first-in-human-surgery-using-fda-cleared-sinaptic-foot-ankle-6460606)
- 2026-03-18 13:02 UTC [SEC Form 4] [SEC Form 4 filed by SiNtx Technologies Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-sintx-technologies-inc-6455763)
- 2026-03-10 13:00 UTC [Insider Buy] [Director Lyons Christopher Michael bought $24,092 worth of shares (8,292 units at $2.91) (SEC Form 4)](https://www.quantisnow.com/insight/director-lyons-christopher-michael-bought-24092-worth-of-shares-8292-6438995)
- 2026-02-25 14:00 UTC [Insider Buy] [Director Moyes Jay M bought $2,910 worth of shares (1,000 units at $2.91), increasing direct ownership by 33% to 4,000 units (SEC Form 4)](https://www.quantisnow.com/insight/director-moyes-jay-m-bought-2910-worth-of-shares-1000-6412167)
- 2026-02-19 14:00 UTC [Insider Buy] [Director Anderson Mark Lewis bought $9,060 worth of shares (3,000 units at $3.02), increasing direct ownership by 20% to 18,000 units (SEC Form 4)](https://www.quantisnow.com/insight/director-anderson-mark-lewis-bought-9060-worth-of-shares-3000-6401639)
- 2026-02-18 13:35 UTC [SEC Form 8-K] [SiNtx Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sintx-technologies-inc-filed-sec-form-8-k-leadership-update-financial-6398441)
- 2026-02-18 13:30 UTC [Leadership Update] [SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms](https://www.quantisnow.com/insight/sintx-technologies-appoints-ryan-elmore-president-to-lead-channel-expansion-6398408)
- 2026-02-11 01:45 UTC [SEC Form 4] [SEC Form 4 filed by Chief Financial Officer Trask Kevin](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-financial-officer-trask-kevin-6385258)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SINT
- Earnings history: https://www.quantisnow.com/earnings/SINT
- Dividend history: https://www.quantisnow.com/dividends/SINT
- Insider transactions: https://www.quantisnow.com/insiders/SINT
- Options chain: https://www.quantisnow.com/options/SINT
- SEC 8-K filings only: https://www.quantisnow.com/company/SINT/8-k
- RSS and alerts for SINT: https://www.quantisnow.com/docs/rss-feeds.md